Clinical Trial Update: Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on palliative treatments for advanced hepatocellular carcinoma, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatectomy, Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED